Comprehensive serum biomarker analysis reveals IL-8 changes as the only predictor of the effectiveness of immune checkpoint inhibitors for patients with advanced non-small cell lung cancer.
Akamatsu H, Koh Y, Nishio M, Goto Y, Hayashi H, Miura S, Tamada K, Kagamu H, Gemma A, Yoshino I, Misumi T, Mouri A, Saito R, Takase N, Yanagitani N, Nokihara H, Seike M, Takamura K, Mori M, Iwasawa S, Nakagawa S, Mitsudomi T.
Akamatsu H, et al. Among authors: nakagawa s.
Lung Cancer. 2024 Nov 9;198:108017. doi: 10.1016/j.lungcan.2024.108017. Online ahead of print.
Lung Cancer. 2024.
PMID: 39571250
Free article.